Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2019-03-07 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates and the loss of original share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and duplicate issuance. The content consists of notifications from the share transfer agent about shareholders reporting lost certificates and requesting duplicates, including folio numbers, certificate numbers, and share counts. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an official regulatory announcement related to share certificate status and compliance with listing regulations. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it contains substantive information rather than a brief notice. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-03-07 English
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificates.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting share certificate loss and related shareholder information. The content is about notifying the stock exchanges of lost share certificates and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory compliance communication related to share certificates but not a financial report or announcement of capital changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-03-02 English
Morepen Laboratories Ltd has informed BSE regarding Issuance of Duplicate Share Certificate.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The content is about informing the exchanges about the issuance of duplicate share certificates to shareholders, listing details of old and new certificate numbers and shareholders' names. There is no financial data, no report or presentation, no voting results, no management or board changes, no earnings or audit information. The document is essentially a regulatory notification about share certificate issuance, which does not fit into financial reports or meeting materials. It is a regulatory announcement related to shareholding documentation but not a major shareholding notification or share issue. Given the nature and content, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-02-27 English
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes details of share certificates issued as duplicates. There is no financial data, earnings information, management discussion, or report attached. The content is an official notification about share certificate issuance, which relates to share capital changes but specifically about duplicate certificates rather than new share issues or capital restructuring. This fits best under the category of Share Issue/Capital Change (SHA), as it concerns changes related to share certificates and capital documentation. The document length is moderate and contains detailed information about the duplicate certificates issued, not just a brief announcement, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the classification is SHA with high confidence.
2019-02-20 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'INVESTORS PRESENTATION (Q3) February 2019' and contains detailed financial performance data for the third quarter of fiscal year 2019 (Q3'FY19). It includes revenue, expenditure, segment-wise growth, product sales, export data, and other operational highlights. The content is structured as a presentation with charts and financial metrics, focusing on business strategy, market position, and financial results for the quarter. There is no indication that this is a full quarterly report with comprehensive financial statements, nor is it an earnings release with only key highlights. Instead, it is a detailed presentation aimed at investors summarizing quarterly performance and business updates. Therefore, the document fits the definition of an Investor Presentation (IP). The document length (12,684 characters) supports that it is a full presentation rather than a brief announcement or summary.
2019-02-04 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Morepen Laboratories Limited regarding the approval of standalone and consolidated unaudited financial results for the quarter and nine months ended 31 December 2018. It includes extensive financial data such as revenue, expenses, profit before tax, net profit, and other comprehensive income. The document also mentions a limited review report by auditors, which is typical for quarterly or interim financial results. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year (quarter and nine months) aligns with the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement of a report but contains substantive financial data and analysis, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is IR with high confidence.
2019-02-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.